Barinthus Biotherapeutics plc / Fundamentals

    Income statement

    Net revenue
    €25.10M
    Cost of goods sold
    -€7.23M
    Gross profit
    €19.43M
    SG&A expenses
    €38.67M
    R&D expenses
    €29.33M
    EBITDA
    -€6.82M
    D&A
    -€4.75M
    EBIT
    €56.56M
    Interest expenses
    -€99.94K
    EBT
    -€44.61M
    Tax expenses
    €1.74M
    Net income
    -€46.41M

    Cash flow statement

    Net deferred tax
    €3.32M
    Non-cash items
    €11.81M
    Changes in working capital
    -€22.27M
    Operating cash flow
    -€38.34M
    Capex
    -€6.10M
    Other investing cash flow
    €0.00
    Net investing cash flow
    €6.10M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    -€1.78M
    Debt repayment
    €0.00
    Other financing cash flow
    €3.20M
    Net financing cash flow
    €1.43M
    Foreign exchange effects
    €9.11M
    Net change in cash
    -€109.19M
    Cash at end of period
    €75.63M
    Free cash flow
    -€44.45M

    Balance sheet

    Cash and cash equivalents
    €74.32M
    Cash and short-term investments
    €74.32M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €12.20M
    Total current assets
    €86.51M
    Property, plant & equipment
    €6.75M
    Goodwill
    €0.00
    Intangible assets
    €17.55M
    Long-term investments
    €0.00
    Other non-current assets
    €813.30K
    Total non-current assets
    €25.11M
    Total assets
    €111.62M
    Accounts payable
    €1.55M
    Short-term debt
    €1.75M
    Other current liabilities
    €6.34M
    Total current liabilities
    €10.96M
    Long-term debt
    €8.57M
    Deferred tax liabilities
    €336.87K
    Other non-current liabilities
    €3.46M
    Total non-current liabilities
    €12.37M
    Total liabilities
    €23.33M
    Common stock
    €861.55
    Retained earnings
    -€239.89M
    Other equity
    -€11.15M
    Total equity
    €88.29M
    Total liabilities and shareholders' equity
    €111.62M

    Company information

    Market capitalization
    €31.52M
    Employees
    105
    Enterprise Value
    -€48.47M

    Company ratios

    Gross margin
    77.4%
    EBITDA margin
    -27.2%
    EBIT margin
    225.3%
    EBT margin
    -177.7%
    Net margin
    -184.9%
    ROE
    -52.6%
    ROA
    -41.6%
    Asset turnover
    22.5%
    FCF margin
    -128.4%
    FCF yield
    -102.3%
    Efficiency ratio
    127.2%
    Net sales per employee
    €239.07K
    Net income per employee
    -€441.96K

    Notifications